Genzyme Corporation Chief Could Reap $221.2M in Sanofi-Aventis (France) Deal

March 8, 2011 |

1 min read

Xconomy -- Genzyme chief executive Henri Termeer is due to take in $158.4 million from French drug giant Sanofi-Aventis’s buyout of his Cambridge, MA-based biotech firm, Bloomberg reported.

Mergers & acquisitions

Sanofi

MORE ON THIS TOPIC

Business and HR concepts for leaders and teams. Circular wooden blocks with hand icons printed on them are connected to wooden blocks with business people icons printed on them. Teamwork concept, business concept

Mergers & acquisitions

Revolution, Ascendis Named Top Buyout Targets as Industry Awaits The Big One

March 19, 2026

·

2 min read

·

Tristan Manalac

Confrontation and opposite opinions concept. Business people hands pulling rope in opposite directions in office showing power and leadership vector illustration

Mergers & acquisitions

Pharma Is Ravenous for M&A Action but Late-Stage Supply Dwindles

March 11, 2026

·

5 min read

·

Annalee Armstrong

Brain tumor medical poster. Cancer, metastasis or benign in the human head or in the nerves, pituitary gland, pineal gland, and membranes that cover the surface of the brain 3D vector illustration

Mergers & acquisitions

Servier Adds to Childhood Brain Tumor Portfolio With $2.5B Day One Buy

March 6, 2026

·

1 min read

·

Annalee Armstrong

Creative collage illustration of financial business. Two businessmen shaking hands for partners agreement. Conceptual illustration of success deal, corporate ethic, connection.

Cardiovascular disease

Alnylam Unites With Tenaya in Potential $1B+ Pact To Find New Genetic Heart Disease Targets

March 5, 2026

·

2 min read

·

Heather McKenzie